Search
C11-12 isoparaffin
go.drugbank.com/drugs/DB11329ApprovedC11-12 isoparaffin is a mixture of branched chain hydrocarbons with 11C or 12C's in the alkyl chain. It is found in cosmetic and personal care products as solvents or skin conditioning agent.
Idraparinux
go.drugbank.com/drugs/DB06406InvestigationalIdraparinux, a synthetic pentasaccharide is an antithrombin-dependent inhibitor of activated factor X. It was developed for the treatment and prevention of thromboembolic events. … As a result, Sanofi stopped the development of the drug.
Categories: Factor Xa InhibitorsLevobetaxolol
go.drugbank.com/drugs/DB09351ApprovedLevobetaxolol is a beta-blocker used to lower the pressure in the eye to treat conditions such as glaucoma. … It was marketed as a 0.5% ophthalmic solution of levobetaxolol hydrochloride under the trade name Betaxon but has been discontinued.
Mus musculus skin
go.drugbank.com/drugs/DB10412ApprovedMus musculus skin or pelt is used in allergenic testing.
Cavia porcellus skin
go.drugbank.com/drugs/DB10416ApprovedCavia porcellus skin or pelt is used in allergenic testing.
Meriones unguiculatus skin
go.drugbank.com/drugs/DB10603ApprovedMeriones unguiculatus skin or pelt is used in allergenic testing.
Capra hircus skin
go.drugbank.com/drugs/DB10604ApprovedCapra hircus skin or pelt is used in allergenic testing.
Oryctolagus cuniculus skin
go.drugbank.com/drugs/DB10607ApprovedOryctolagus cuniculus skin or pelt is used in allergenic testing.
Influenza B virus B/Michigan/01/2021 antigen (formaldehyde inactivated)
go.drugbank.com/drugs/DB16917ApprovedInactivated vaccines contain a virus particle that has been grown in media and then subsequently killed, or inactivated, through exposure to heat or chemicals such as formaldehyde. … These vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which results in an immunological defense against future exposure to the virus, or "antigen
TAK-428
go.drugbank.com/drugs/DB05499ExperimentalTAK-428 is a drug for treating diabetic neuropathy. … It is based on the novel concept that peripheral nervous tissue that was damaged by diabetes can be repaired and regenerated by stimulating an increase in neurotrophic factors.